Egetis Therapeutics AB (publ) (STO: EGTX)
Sweden
· Delayed Price · Currency is SEK 6.05
+0.08 (1.34%)
Jan 17, 2025, 5:24 PM CET
Egetis Therapeutics AB Revenue
Egetis Therapeutics AB had revenue of 9.40M SEK in the quarter ending September 30, 2024, a decrease of -22.95%. This brings the company's revenue in the last twelve months to 67.90M, up 121.17% year-over-year. In the year 2023, Egetis Therapeutics AB had annual revenue of 57.60M with 154.87% growth.
Revenue (ttm)
67.90M
Revenue Growth
+121.17%
P/S Ratio
25.41
Revenue / Employee
1.74M
Employees
28
Market Cap
2.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57.60M | 35.00M | 154.87% |
| Dec 31, 2022 | 22.60M | -15.60M | -40.84% |
| Dec 31, 2021 | 38.20M | -2.46M | -6.05% |
| Dec 31, 2020 | 40.66M | -41.90M | -50.75% |
| Dec 31, 2019 | 82.56M | 54.35M | 192.66% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 25.44B |
| Getinge AB | 33.59B |
| Sectra AB | 3.14B |
| Camurus AB | 1.69B |
| Medicover AB | 22.60B |
| Vitrolife AB | 3.56B |
| Bonesupport Holding AB | 814.46M |
| Elekta AB | 17.72B |